Stay updated on Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.

Latest updates to the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page history now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check25 days agoChange DetectedThe government funding/operating-status notice was removed from the page. No trial-related content changed.SummaryDifference0.2%

- Check39 days agoChange DetectedIPDSharing was added to the study record; multiple versions updated Study Status and Contacts/Locations.SummaryDifference0.0%

- Check68 days agoChange DetectedPage content updated: new funding-status notice and updated 2025 dates with a new revision (v3.2.0) replacing v3.1.0; older date and revision removed.SummaryDifference7%

- Check75 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check89 days agoChange DetectedUpdated the page to Revision: v3.0.2 (replacing v3.0.1) and removed the 'Back to Top' element as a minor UI cleanup.SummaryDifference0.4%

Stay in the know with updates to Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.